1887

Journal of General Virology header logo

Volume 78, Issue 11

Cooperative interaction between Bcl-2 and Epstein-Barr virus latent membrane protein 1 in the growth transformation of human epithelial cells Free

Abstract

The Epstein-Barr virus latent membrane protein 1 (LMP-1) is essential for virus-induced B cell immortalization and can protect B lymphoma cell lines from apoptosis signals via induction of cellular Bcl-2 expression. However, we have reported that high-level expression of LMP-1 in epithelial cells (RHEK-1 cells) itself induces apoptosis. This apoptotic event occurs in the absence of detectable Bcl-2 expression in the LMP-1- transfected epithelial cells. In this study, we transfected the gene into the LMP-1-containing cells and examined the effect of Bcl-2 upon LMP-1- mediated apoptosis, and upon the growth phenotype of the transfected cells. The results show that ectopic expression of Bcl-2 specifically blocks apop- totic death induced by LMP-1. This was observed from cell culture viability and from gel electrophoresis and flow cytometric assays of the degree of DNA fragmentation in cultured cells. Furthermore, co-expression of LMP-1 and Bcl-2 in RHEK-1 cells enabled the cells to grow under low-serum conditions and to form colonies in semi-soft agar medium. These results suggest, therefore, that these two proteins play important complementary roles in the process of EBV-associated epithelial cell transformation. It appears significant, therefore, that LMP-1 and Bcl-2 are frequently co-expressed in the malignant cells of an EBV-positive epithelial tumour, nasopharyngeal carcinoma.

  • Published Online:
© Society for General Microbiology 1997
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-11-2975
1997-11-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/11/9367385.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-11-2975&mimeType=html&fmt=ahah

References

  1. Abdallali F., Harrington E. A., Evan G. I. 1992; Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554–556
     [Google Scholar]
  2. Askew D. S., Ashmun R. A., Simmons B. C., Cleveland J. L. 1991; Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915–1922
     [Google Scholar]
  3. Baichwal V. R., Sugden B. 1988; Transformation ofBalb/3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 2:461–467
     [Google Scholar]
  4. Chen-Levy Z., Cleary M. L. 1990; Membrane topology of the Bcl- 2 proto-oncogenic protein demonstrated in vitro. Journal of Biological Chemistry 25:4929–4933
     [Google Scholar]
  5. Cohen J. I., Wang F., Kieff E. 1991; Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. Journal of Virology 65:2545–2554
     [Google Scholar]
  6. Dawson C. W., Rickinson A. B., Young L. S. 1990; Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777–780
     [Google Scholar]
  7. Epstein M. A., Achong B. C., Barr Y. M. 1964; Virus particles in cultured lymphoblasts from Burkittʹs lymphoma. Lancet i:702–703
     [Google Scholar]
  8. Evan G. I., Littlewood T. D. 1993; The role of c-myc in cell growth. Current Opinions in Genetic Development 3:44–49
     [Google Scholar]
  9. Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood T. D., Land H., Brooks M., Waters C. M., Penn L. Z., Hancock D. C. 1992; Induction of apoptosis in fibroblasts by c-Myc protein. Cell 69:119–128
     [Google Scholar]
  10. Fahraeus R., Fu J. L., Ernberg I., Finke I., Rowe M., Klein G., Falk K., Nilsson E., Yadav M., Busson P., Tursz T., Kallin B. 1988; Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. International Journal of Cancer 42:329–338
     [Google Scholar]
  11. Fahraeus R., Rymo L., Rhim J. S., Klein G. 1990; Morphological transformation of human keratinocytes expressing the LMP-1 gene of Epstein-Barr virus. Nature 345:447–449
     [Google Scholar]
  12. Field J. K., Spandidos D. A. 1990; The role of ras and myc oncogenes in human solid tumors and their relevance in diagnosis and prognosis. Anticancer Research 10:1–22
     [Google Scholar]
  13. Gregory C. D., Dive C., Henderson S., Smith C. A., Williams G. T., Gordon J., Rickinson A. B. 1991; Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612–614
     [Google Scholar]
  14. Henderson S., Rowe M., Gregory C. P., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. B. 1991; Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107–1115
     [Google Scholar]
  15. Henle W., Henle G., Burtin P., Cachin Y., Clifford P., de Schryver A., de The G., Diehl V., Ho H. C., Klein G. 1970; Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasmas and control group. Journal of the National Cancer Institute 44:225–231
     [Google Scholar]
  16. Hockenberry D., Nunez G., Milliman C., Schreiber R. D., Kors-meyer S. J. 1990; Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336
     [Google Scholar]
  17. Hunter T. 1991; Cooperation between oncogenes. Cell 64:249–270
     [Google Scholar]
  18. Kaye K. M., Izumi K. M., Kieff E. 1993; Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proceedings of the National Academy of Sciences, USA 90:9150–9154
     [Google Scholar]
  19. Kieff E. 1996; Epstein-Barr virus and its replication. In Fields Virology, 3rd edn. pp. 2343–2396 Fields B. N., Knipe D. M., Howley P. M. Edited by Philadelphia: Lippincott-Raven;
     [Google Scholar]
  20. Liebowitz D., Wang D., Kieff E. 1986; Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. Journal of Virology 58:233–237
     [Google Scholar]
  21. Liebowitz D., Kopan R., Fuchs E., Sample J., Kieff E. 1987; An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Molecular and Cellular Biology 7:2299–2308
     [Google Scholar]
  22. Lu Q. L., Elia G., Lucas S., Alero Thomas J. 1993a; bcl-2 protooncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. International Journal of Cancer 53:29–35
     [Google Scholar]
  23. Lu Q. L., Poulson R., Wong L., Hanby A. M. 1993b; Bcl-2 expression in adult and embryonic non-haematopoietic tissues. Journal of Pathology 169:431–437
     [Google Scholar]
  24. Lu P. J., Lu Q. L., Rughetti A., Taylor-Papadimitriou J. 1995; bcl- 2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. Journal of Cell Biology 129:1363–1378
     [Google Scholar]
  25. Lu J. J. Y., Chen J. Y., Hsu T. Y., Yu W. C. Y., Su I. J., Yang C. S. 1996; Induction of apoptosis in epithelial cells by Epstein-Barr virus latent membrane protein 1. Journal of General Virology 77:1883–1892
     [Google Scholar]
  26. Luscher B., Eisenman R. N. 1990; New light on Myc and Myb. Part I. Myc. Genes & Development 4:2025–2035
     [Google Scholar]
  27. McDonnell T. J., Korsmeyer S. J. 1991; Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for t(14; 18). Nature 349:254–256
     [Google Scholar]
  28. McDonnell T. J., Deane N., Platt F. M., Nunez G., Jaeger U., McKearn J. P., Korsmeyer S. J. 1989; bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79–88
     [Google Scholar]
  29. Mann K. P., Staunton D., Thorley-Lawson D. A. 1985; Epstein- Barr virus-encoded protein found in plasma membranes of transformed cells. Journal of Virology 55:710–720
     [Google Scholar]
  30. Mann G. J., Dyne M., Musgrave E. A. 1987; Immunofluorescence quantification of ribonucleotide reductase M1 subunit and correlation with DNA content by flow cytometry. Cytometry 8:509–517
     [Google Scholar]
  31. Martin J. M., Veis D., Korsmeyer S. J., Sugden B. 1993; Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. Journal of Virology 67:5269–5278
     [Google Scholar]
  32. Nataraj A., Pathak S., Hopwood V. 1994; bcl-2 oncogene blocks differentiation and extends viability but does not immortalize normal human keratinocytes. International Journal of Oncology 4:1211–1218
     [Google Scholar]
  33. Nunez G., Seto M., Seremetis S., Ferrero D., Grignani F., Korsmeyer S. J., Dalla-Favera R. 1989; Growth- and tumor- promoting effects of deregulated Bcl-2 in human B-lymphoblastoid cells. Proceedings of the National Academy of Sciences, USA 86:4589–4593
     [Google Scholar]
  34. Old L. J., Boyse W. A., Oettgen H. F., Deharven E., Geering G., Williamson B., Clifford P. 1966; Precipitating antibodies in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proceedings of the National Academy of Sciences, USA 56:1699–1704
     [Google Scholar]
  35. Reed J. C., Tsujimoto Y., Alpers J. D., Croce C. M., Nowell P. C. 1987; Regulat ion of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 236:1295–1299
     [Google Scholar]
  36. Reed J. C., Cuddy M., Halder S., Croce C., Nowell P., Makover D., Bradley K. 1990a; Bcl-2-mediated tumorigenicity of a human T- lymphoid cell line : synergy with c-myc and inhibition by bcl-2 antisense. Proceedings of the National Academy of Sciences, USA 87:3660–3664
     [Google Scholar]
  37. Reed J. C., Halder S., Croce C. M., Cuddy M. P. 1990b; Complementation by bcl-2 and C-HA-ras oncogenes in malignant transformation of rat embryo fibroblasts. Molecular and Cellular Biology 10:4370–4374
     [Google Scholar]
  38. Reed J. C., Taiwar S. H., Cuddy M., Baffy G., Williamson J., Rapp U. R., Fisher G. J. 1991; Mitochondrial protein p26 Bcl-2 reduces growth factor requirements of NIH3T3 fibroblasts. Experimental Cell Research 195:227–283
     [Google Scholar]
  39. Rowe M., Peng-Pilon M., Huen D. S., Hardy R., Croom-Carter D., Lundgren E., Rickinson A. B. 1994; Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein 1 : a B-cell-specific response that is delayed relative to NF-KB activation and to induction of cell surface markers. Journal of Virology 68:5602–5612
     [Google Scholar]
  40. Shi Y., Glynn J. M., Guilbert L. J., Cotter T. G., Bissonnette R. P., Green D. R. 1992; Role for c-myc in activation-induced apoptotic cell death in T cell lymphomas. Science 257:212–214
     [Google Scholar]
  41. Spencer C. A., Groudine M. 1991; Control of c-myc regulation in normal and neoplastic cells. Advanced Cancer Research 56:1–48
     [Google Scholar]
  42. Strasser A., Harris A. W., Bath M. L., Cory S. 1990; Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331–333
     [Google Scholar]
  43. Tomkinson B., Robertson E., Kieff E. 1993; Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocytes growth transformation. Journal of Virology 67:2014–2025
     [Google Scholar]
  44. Tsujimoto Y. 1989; Overexpression of the human bcl-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proceedings of the National Academy of Sciences, USA 86:1958–1962
     [Google Scholar]
  45. Vaux D. L., Cory S., Adams J. M. 1988; bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre- B cells. Nature 335:440–442
     [Google Scholar]
  46. Wang D., Liebowitz D., Kieff E. 1985; An EBV membrane protein expressed in immortalized lymphocytes transformed established rodent cells. Cell 43:831–840
     [Google Scholar]
  47. Wang D., Liebowitz D., Wang F., Gregory C., Rickinson A. B., Larson R., Springer T., Kieff E. 1988; Epstein-Barr virus latent infection membrane protein alters the human B-lymphocytes phenotype: deletion of the amino terminus abolishes activity. Journal of Virology 63:4173–4184
     [Google Scholar]
  48. Wilson J. B., Weinberg W., Johnson R., Yuspa S., Levine A. J. 1990; Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315–1327
     [Google Scholar]
  49. Young L. S., Dawson C. W., Clark D., Rupani H., Busson P., Tursz T., Johnson A., Rickinson A. B. 1988; Epstein-Barr virus gene expression in nasopharyngeal carcinoma. Journal of General Virology 69:1051–1061
     [Google Scholar]
  50. Young L., Alfieri C., Hennessy K., Evans H., O’Hara C., Anderson K. C., Ritz J., Shapiro R. S., Rickinson A. B., Kieff E., Cohen J. I. 1989; Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. New England Journal of Medicine 321:1080–1085
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-11-2975
Loading
Cooperative interaction between Bcl-2 and Epstein-Barr virus latent membrane protein 1 in the growth transformation of human epithelial cells
J. Gen. Virol. 78, 2975 (1997); https://doi.org/10.1099/0022-1317-78-11-2975
/content/journal/jgv/10.1099/0022-1317-78-11-2975
/content/journal/jgv/10.1099/0022-1317-78-11-2975
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error